Perceptive eClinical and Kayentis Partner to Deliver Integrated eCOA-IRT Solution for Streamlined Clinical Trials
Perceptive eClinical, a recognized leader in Interactive Response Technology (IRT), has entered into a strategic partnership with Kayentis, a global provider of electronic clinical outcome assessment (eCOA) solutions. Together, the two companies aim to deliver a fully integrated, best-in-class eCOA-IRT solution designed to simplify and enhance the execution of modern clinical trials. This collaboration marks a significant step toward reducing the growing complexity associated with digital systems used in global clinical research.
As clinical trials continue to evolve, they have become increasingly dependent on multiple digital platforms to manage patient data, trial logistics, and outcomes. However, this reliance on separate systems often results in fragmented workflows, inefficiencies, and increased operational burden for trial sponsors and contract research organizations (CROs). By combining their specialized technologies, Perceptive eClinical and Kayentis seek to address these challenges through a unified and interoperable solution.
At the core of this partnership is the seamless integration of IRT and eCOA platforms. IRT systems are essential for managing patient randomization, drug supply, and trial logistics, while eCOA solutions are used to capture patient-reported outcomes and other clinical data electronically. Traditionally, these systems operate independently, requiring users to manually transfer data between platforms. This often leads to duplicate data entry, repetitive workflows, and additional verification steps, all of which can slow down trial progress and increase the risk of errors.
The integrated solution developed by Perceptive eClinical and Kayentis eliminates these inefficiencies by creating a streamlined workflow that connects both systems. By enabling real-time data exchange and synchronized processes, the solution significantly reduces the need for manual intervention. This not only improves operational efficiency but also enhances data accuracy and consistency across the trial lifecycle.
One of the primary benefits of this integration is the reduction of administrative burden on clinical trial teams. Trial centers and research staff often face significant workload pressures due to the complexity of managing multiple systems. With a unified platform, users can access both IRT and eCOA functionalities through a single interface, simplifying daily operations and improving the overall user experience. This streamlined approach allows research teams to focus more on patient care and less on administrative tasks.
According to Mario Papillon, CEO of Perceptive eClinical, the partnership reflects a shared commitment to transforming the clinical technology landscape. He emphasized that integrating two highly specialized platforms enables the creation of a harmonized solution that simplifies trial operations, reduces workload for site teams, and improves the quality of data available to sponsors and CROs. This alignment of vision between the two companies underscores their dedication to advancing innovation in clinical research.
Guillaume Juge, CEO of Kayentis, echoed this sentiment, noting that the collaboration builds on Kayentis’ mission to simplify clinical trial execution. He highlighted that the combined solution delivers clearer processes, reduced system administration, and more reliable data for decision-making. By prioritizing usability and integration, the partnership aims to support trial sites with intuitive tools that enhance both efficiency and accuracy.
The integrated eCOA-IRT solution offers several key features designed to optimize clinical trial operations. One of the most notable is unified user access, which allows users to navigate both systems seamlessly without the need for multiple logins or interfaces. This ensures a consistent and efficient user experience across platforms.
Another important feature is the automatic transmission of patient data between systems. Information such as patient identification numbers and personal details can be shared in real time, eliminating the need for repetitive manual input. This not only saves time but also reduces the likelihood of data entry errors, which can compromise trial integrity.
In addition, the solution includes automated workflows that are triggered by shared resources across the integrated platforms. These workflows improve coordination among research teams by ensuring that actions in one system automatically prompt corresponding updates in the other. This level of synchronization enhances communication and helps maintain alignment throughout the trial process.
Collectively, these features contribute to faster and more efficient daily operations. Trial sites benefit from reduced workload, while sponsors and CROs gain access to higher-quality data that supports more informed decision-making. The ability to streamline processes and improve data reliability is particularly valuable in complex, multi-site trials where coordination and accuracy are critical.
Beyond its immediate functional advantages, the partnership also simplifies broader aspects of clinical trial management. Study sponsors can benefit from a single contractual agreement, which reduces administrative complexity and accelerates the initiation phase of trials. Coordinated project timelines and a unified execution team further enhance efficiency, ensuring that studies progress smoothly from initiation to database lock.
The collaboration also reflects a forward-looking approach to clinical trial innovation. Both Perceptive eClinical and Kayentis have committed to expanding the interoperability of their systems over time. By developing a shared roadmap for deeper integration, they aim to create a more connected and cohesive clinical technology ecosystem. This ongoing development will enable additional capabilities and further streamline the execution of trials in the future.
Perceptive eClinical brings over 30 years of experience in IRT and supply chain management to the partnership. The company has supported more than 3 million patients and contributed to over 500 regulatory approvals worldwide. Its flagship platform, ClinPhone Pro, is known for its flexibility, scalability, and ability to integrate with other systems, making it well-suited for complex clinical trials across various therapeutic areas.
Kayentis, on the other hand, is a recognized leader in eCOA and decentralized clinical trial solutions. With more than 20 years of experience, the company has supported over 400 clinical trials in 90 countries. Its technology is designed to be patient-centric and science-driven, focusing on improving data quality while making participation easier for both patients and trial sites.
The partnership between these two organizations combines their respective strengths to deliver a solution that addresses the evolving needs of the clinical research industry. As trials become more complex and decentralized, the demand for integrated, user-friendly technologies continues to grow. By eliminating silos and enabling seamless data flow, the eCOA-IRT solution positions itself as a valuable tool for modern clinical trial execution.
In conclusion, the collaboration between Perceptive eClinical and Kayentis represents a significant advancement in clinical trial technology. By integrating IRT and eCOA systems into a single, cohesive platform, the partnership addresses key challenges related to fragmentation, inefficiency, and data quality. With its focus on simplification, interoperability, and user experience, the solution is poised to enhance the efficiency and effectiveness of clinical trials on a global scale.
About Kayentis
Kayentis is a global expert in electronic clinical outcome assessment (eCOA) and decentralized clinical trial solutions, with over 20 years of experience assisting more than 400 trials in 90 countries. Kayentis provides science-driven, patient-centered technology designed to improve data quality and streamline participation processes for trial centers and patients.
